Rani Therapeutics
VerifiedDevelops bio-therapeutics technology for the oral delivery of large drug molecule
Launch date
Employees
Ownership
Market cap
$236m
Net debt
-
Firm valuation
$276—414m (Public information from Dec 2020)
Share price
$11.95 RANI
San Jose California (HQ)
RELATED LANDSCAPES AND LISTS
Financials
Edit| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $4m | Series A Not yet verified | |
| N/A | Series B | ||
| $15.5m | Series C | ||
| N/A | Late VC | ||
| $39m | Series D | ||
| N/A | Seed | ||
* | $53m | Late VC | |
| N/A | $69m | Series E | |
| N/A | $73m | IPO | |
* | N/A | $45m | Post IPO Debt Not yet verified |
| Total Funding | $176m | ||
Recent News about Rani Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.